Celltrion Gets Ready To Face The Competition After European Bevacizumab Nod
Vegzelma CT-P16 Biosimilar Rival To Avastin Receives CHMP Positive Opinion
• By David Wallace
Celltrion faces a crowded European market for bevacizumab • Source: Shutterstock 
